期刊文献+

重视结直肠癌肝转移生物学行为的评价

Precise evaluation of biological behavior for colorectal cancer liver metastases
原文传递
导出
摘要 近年来结直肠癌肝转移的发生率逐年升高,手术切除是肝转移患者获得长期生存的重要手段,但是手术切除后复发率达到60%~70%。因此,明确结直肠癌肝转移患者术后复发的高危因素,精准评价肿瘤生物学行为,有助于更好地选择术前治疗方案、局部治疗时机以及手术方式,也是提高肝转移患者手术切除后生存获益的关键。本文详细阐述了目前研究比较明确的影响结直肠癌肝转移术后复发和生存的主要因素,包括临床危险评分、术前化疗反应性、基因状态和原发肿瘤位置。 The incidence of colorectal cancer liver metastases(CRLM)has been gradually increased in recent years.Surgical resection is the most important treatment method for CRLM patients,but the recurrence rate was as high as 60%-70%after surgical resection.Therefore,it is very important to clarify the high-risk prognostic factors for tumor recurrence in patients with CRLM after surgery.Based on the prognostic factors we can accurately evaluate the biological behavior of each patient before surgery and select suitable preoperative chemotherapy regimen,timing and method of localized treatment for them.Thereby the survival benefit from surgical resection of those patients could be maximized.In this article we discussed several important factors affecting the tumor recurrence and survival of patients with CRLM undergoing surgical resection,including clinical risk factor score,preoperative chemotherapy response,the genetic status and the primary tumor location,and explain in detail.
作者 邢宝才 徐达 Xing Baocai;Xu Da(Key laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Hepatopancreatobiliary Surgery DepartmentⅠ,Peking University Cancer Hospital&Institute,Beijing 100142,China)
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2020年第7期481-484,共4页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(81874143,31971192) 北京市自然科学基金(7192035)。
关键词 结直肠肿瘤 肝转移 外科手术 Colorectal neoplasms Liver metastases Surgical procedures operative
  • 相关文献

参考文献2

二级参考文献36

  • 1赵东兵,单毅,王成峰,吴健雄,邵永孚,赵平.伴有同时性肝转移结直肠癌的外科治疗[J].中华肿瘤杂志,2007,29(7):552-554. 被引量:7
  • 2Lochan R,White SA, Manas DM. Liver resection for colorectalliver metastasis[ J]. Surg Oncol, 2007,16(1) :33-45.
  • 3Kopetz S, Chang GJ, Overman MJ, et al. Improved survival inmetastatic colorectal cancer is associated with adoption of hepaticresection and improved chemotherapy [ J ]. J Clin Oncol, 2009,27(22):3677-3683.
  • 4Minagawa M,Makuuchi M, Torailli G, et al. Extension of thefrontiers of surgical indications in the treatment of liver metastasesfrom colorectal cancer; long-term results [ J]. Ann Surg, 2000,231(4)-.487499.
  • 5Ercolani G,Grazi GL, Ravaioli M,et al. Liver resection for mul-tiple colorectal metastases : influence of parenchymal involvementand total tumor volume,vs number or location,on long-term sur-vival [J]. Archives of Surgery, 2002,137 (10) :1187-1192.
  • 6Poston GJ. Surgical strategies for colorectal liver metastases[ J].Surg Oncol, 2004,13(2-3) : 125-136.
  • 7Chirica M, Leconte M, Oberlin 0, et al. Surgical treatment of li-ver metastasis in patients with colorectal cancer[J]. Presse Med,2012,41(l);58-67.
  • 8Seehofer D, Neuhaus P. Current status of multimodal therapy forcolorectal liver metastases [ J ]. Zentralbl Chir, 2011,136 (4):343-351.
  • 9Brouquet A, Andreou A, Vauthey JN. The management of solitarycolorectal liver metastases[ J]. Surgeon, 2011 ,9(5) :265-272.
  • 10Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection ofcolorectal carcinoma metastases to the liver : a prognostic scoringsystem to improve case selection, based on 1568 patients. Associa-tion Francaise de Chirurgie [ J ]. Cancer, 1996, 77 ( 7 ):1254-1262.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部